Skip to main content

Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

Description
Examines the impact of 2006 federal legislation allowing waivered physicians to prescribe and expand FDA approved buprenorphine as a treatment for opioid use disorder to a maximum of 100 patients. Discusses buprenorphine distribution by both urban and rural waivered physicians, opioid treatment programs, and treatment facilities for substance abuse.
Author(s)
Bradley D. Stein, Rosalie L. Pacula, Adam J. Gordon, et al.
Location
The Milbank Quarterly, 93(3), 561-583
Date
09/2015
Type
Document
Tagged as
Behavioral health workforce · Clinics · Illicit drug use · Legislation and regulations · Prescription drug abuse · Substance abuse